GSDME and lung carcinoma: GSDMD or gasdermin-E (GSDME) in human B leukemic cells can be activated by chimeric antigen receptor T cell-released granzyme B [35] and activated GSDMD is required for an optimal cytotoxic T lymphocyte response to lung cancer cells [36].